Research Article

Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents

Table 1

Biodistribution of 131I-H33258 in necrotic-muscle bearing mice models.

OrganUptake (% ID/g)
3 h6 h12 h24 h

Blood0.77 ± 0.130.46 ± 0.010.13 ± 0.040.06 ± 0.02
Brain0.03 ± 0.010.02 ± 0.020.01 ± 0.000.01 ± 0.00
Thyroid0.57 ± 0.110.34 ± 0.080.23 ± 0.030.05 ± 0.01
Lung0.48 ± 0.100.39 ± 0.090.32 ± 0.010.11 ± 0.02
Heart0.18 ± 0.060.12 ± 0.010.06 ± 0.010.04 ± 0.01
Liver1.49 ± 0.151.02 ± 0.300.57 ± 0.100.24 ± 0.04
Spleen1.14 ± 0.150.67 ± 0.110.34 ± 0.370.14 ± 0.03
Stomach1.62 ± 0.120.81 ± 0.170.44 ± 0.010.17 ± 0.08
Pancreas0.30 ± 0.060.32 ± 0.060.07 ± 0.000.05 ± 0.01
S intestine0.61 ± 0.140.40 ± 0.110.06 ± 0.010.04 ± 0.02
L intestine0.47 ± 0.100.24 ± 0.200.06 ± 0.020.04 ± 0.02
Kidney1.11 ± 0.160.84 ± 0.130.56 ± 0.050.17 ± 0.05
Bladder2.13 ± 0.281.60 ± 0.440.09 ± 0.020.05 ± 0.04
V muscle0.16 ± 0.030.10 ±0.030.03 ± 0.010.02 ± 0.01
N muscle0.93 ± 0.120.61 ± 0.080.35 ± 0.030.24 ± 0.04
N/V ratio5.81 ± 0.556.19 ± 0.9210.70 ± 1.729.75 ± 1.10

Data are presented as mean ± SD for four mice. S intestine: small intestine; L intestine: large intestine; V muscle: viable muscle; N muscle: necrotic muscle; N/V ratio: necrotic/viable muscle ratio. , compared with the uptake values of 131I-H33258 in viable muscle at each time point.